Redmile Group, LLC Bio N Tech Se Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q3 2024
A detailed history of Redmile Group, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Redmile Group, LLC holds 154,456 shares of BNTX stock, worth $19 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
154,456Holding current value
$19 Million% of portfolio
1.2%Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.02 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$555 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$536 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$222 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...